A new monitoring device by a Georgia Tech professor is like “an Apple Watch for your heart”

It aims to help heart failure patients by monitoring heart data at home

280
Paired to Cardiotag, this phone shows the person’s shows ECG, SCG, and PPG signals

Photograph courtesy of Georgia Tech

When a patient is in heart failure, they are often hospitalized over and over again, with high mortality rates. But Georgia Tech professor Omer Inan is hoping to change that with an innovation that recently received FDA clearance. Called CardioTag, the device, which uses wearable sensors to measure physiological signals from the heart, is paired with start-up company CardioSense’s AI to change the way heart failure patients are monitored, which could reduce hospitalizations.

Inan says part of that is because the right tools to monitor them at home and in the hospital haven’t been available. Now, with CardioTag, clinicians can get comprehensive information to see patterns and hopefully intervene before it becomes an emergency. Inan has been working on it while at Georgia Tech, in collaboration with the University of California San Francisco.

Cardiotag recently received FDA approval

Photograph courtesy of Georgia Tech

CardioTag has three signals it monitors: electrocardiograms, or the heart’s electrical activity; photoplethysmograms, or the pulse signal; and seismocardiograms, or the heart’s mechanical vibrations. “Seismocardiograms are the tiny earthquakes of your chest in response to your heartbeat,” he says. Inan has been studying seismocardiograms since he was in graduate school at Stanford decades ago, and it was first measured in astronauts in the 1960s. “That signal gives us the most important information, which is the mechanical activity of the heart: how it’s being filled and pumping.”

Today, clinicians often rely on implantable sensors that measure cardiac filling pressures. However, it’s invasive, has risks, and pricey, costing close to $30,000.

Professor Omer Inan (left) and fifth-year ECE PhD student Farhan Rahman demonstrate a prototype wristband that senses the body’s rising stress response and administers electrical stimulation to counteract it.

Photograph courtesy of Georgia Tech

Now, CardioTag’s wearable device and companion app can monitor all three markers to give the patient, caregiver, and hospital staff more comprehensive data. “It may allow them to stay at a better level of filling pressure at home, and not have those pressures go up and cause hospitalization,” says Inan. “It’s kind of like an Apple Watch for your heart.”

CardioTag, which will be available by prescription, plans to start early stage pilots and commercialization pilots later this year, with a full ramp-up in 2027.

Advertisement